Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:4 курс / Дерматовенерология / Malignant Melanoma.pptx
X
- •Malignant
- •RISK FACTORS
- •Familial Atypical Mole Melanoma
- •Xeroderma Pigmentosum
- •Ultraviolet light
- •The ABCDEs of Melanoma Diagnosis
- •TYPES OF MELANOMA
- •NODULAR
- •SUPERFICIAL SPREADING
- •ACRAL LENTIGINOUS MELANOMA
- •SUBUNGAL MELANOMA
- •LENTIGO MALIGNA MELANOMA
- •AMELANOTIC MELANOMA
- •Mucosal melanoma
- •Ocular melanoma
- •Skin biopsy
- •Breslow Thickness:
- •Clark Level
- •Stage 0: (TisN0M0).
- •Stage I: Local disease - superficial
- •Stage II: Local disease - deep invasion.
- •Stage III: Regional disease
- •Stage IV: Metastatic disease
- •Prognostic factors
- •Sentinel lymph node biopsy
- •Sentinel lymph node mapping and biopsy
- •Adjuvant therapy
- •IPILIMUMAB
- •IFN - Side effects
- •Treatment Options for advanced Melanoma
- •Imunotherapy
- •Ipillimumab (Yervoy)
- •Anti PD1 therapy : Opdivo
- •Opdivo Monotherapy Phase 3 Trial: Improved OS Versus Dacarbazine in BRAF Wild-type,
- •59Updated Results From a Phase III Trial of Nivolumab Combined With Ipilimumab in
- •62Safety Summary
- •J.M. Michot et al. European Journal of Cancer 54 (2016)
- •Boutros et al. Nature Reviews Clinical Oncology Volume: 13, Pages:473–486 Year published:(2016)
- •Boutros et al. Nature Reviews Clinical Oncology 13, 473–486 (2016)
- •Webber JS , Safety profile of nivolumab in patients with advanced melanoma, Pooled
J.M. Michot et al. European Journal of Cancer 54 (2016)
Boutros et al. Nature Reviews Clinical Oncology Volume: 13, Pages:473–486 Year published:(2016)
Boutros et al. Nature Reviews Clinical Oncology 13, 473–486 (2016)
Webber JS , Safety profile of nivolumab in patients with advanced melanoma, Pooled Analysis. ASCO 2016 ( Poster).
Соседние файлы в папке Дерматовенерология